Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock

European Heart Journal: Acute Cardiovascular Care

Volumn 7, Issue 8, 2018, Pages 755-765

  Garan, A Reshad ^a   Eckhardt, Christina ^a   Takeda, Koji ^a   Topkara, Veli K ^a   Clerkin, Kevin ^a   Fried, Justin ^a   Masoumi, Amirali ^a   Demmer, Ryan T ^b   Trinh, Pauline ^b   Yuzefpolskaya, Melana ^a   Naka, Yoshifumi ^a   Burkhoff, Dan ^a   Kirtane, Ajay ^a   Colombo, Paolo C ^a   Takayama, Hiroo ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

cardiogenic shock; ECMO; mechanical circulatory support; Myocardial infarction; recovery; ventricular assist device

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; HYPERTENSIVE FACTOR; LACTIC ACID;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BLOOD CLOT LYSIS; CARDIAC INDEX; CARDIOGENIC SHOCK; COHORT ANALYSIS; CORONARY ANGIOGRAPHY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUBSTITUTION THERAPY; SURVIVAL PREDICTION; SYSTOLIC BLOOD PRESSURE; VENTILATOR WEANING; COMPLICATION; EPIDEMIOLOGY; HEART ASSIST DEVICE; HEART INFARCTION; MIDDLE AGED; MORTALITY; NEW YORK; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW YORK; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85049070113     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872617740834     Document Type: Article

References (22)

1. Goldberg RJ, Makam RC, Yarzebski J. Decade-long trends (2001–2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2016; 9: 117–125
2. Stretch R, Sauer CM, Yuh DD. National trends in the utilization of short-term mechanical circulatory support: Incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014; 64: 1407–1415
3. Ouweneel DM, Eriksen E, Sjauw KD. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69: 278–287
4. Takayama H, Truby L, Koekort M. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013; 32: 106–111
5. Hochman JS, Sleeper LA, Webb JG. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625–634
6. Thiele H, Zeymer U, Neumann FJ. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287–1296
7. Burkhoff D, Cohen H, Brunckhorst C. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469.e1–e8
8. Seyfarth M, Sibbing D, Bauer I. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584–1588
9. Truby L, Naka Y, Kalesan B. Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. Eur J Cardiothorac Surg 2015; 48: 322–328
10. Takayama H, Soni L, Kalesan B. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 2014; 7: 799–806
11. Kirklin JK, Naftel DC, Pagani FD. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 2015; 34: 1495–1504
12. Acharya D, Loyaga-Rendon RY, Pamboukian SV. Ventricular assist device in acute myocardial infarction. J Am Coll Cardiol 2016; 67: 1871–1880
13. Dang NC, Topkara VK, Leacche M, John R. Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study. J Thorac Cardiovasc Surg 2005; 130: 693–698
14. Chou J, Bermudez C, Kormos R. Permanent continuous flow left ventricular assist devices use after acute stabilization for cardiogenic shock in acute myocardial infarction. ASAIO J 2017; 63: e13–e17
15. Muller G, Flecher E, Lebreton G. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 2016; 42: 370–378
16. Pöss J, Köster J, Fuernau G. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69: 1913–1920
17. Lee WC, Fang CY, Chen HC. Associations with 30-day survival following extracorporeal membrane oxygenation in patients with acute ST segment elevation myocardial infarction and profound cardiogenic shock. Heart Lung 2016; 45: 532–537
18. Chung SY, Tong MS, Sheu JJ. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention. Int J Cardiol 2016; 223: 412–417
19. Fincke R, Hochman JS, Lowe AM. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. J Am Coll Cardiol 2004; 44: 340–348
20. Basir MB, Schreiber TL, Grines CL. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 2017; 119: 845–851
21. O’Neill WW, Schreiber T, Wohns DH. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: Results from the USpella Registry. J Interv Cardiol 2014; 27: 1–11
22. O’Neill W, Basir M, Dixon S. Feasibility of early mechanical support during mechanical reperfusion of acute myocardial infarct cardiogenic shock. JACC Cardiovasc Interv 2017; 10: 624–625